Glickman Richard M
SEC insider (Form 3/4/5 filer). CIK 0001352637. Director at enGene Therapeutics Inc. (ENGN) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in SAINT-LAURENT.
Companies Glickman Richard M has filed insider reports for
- enGene Therapeutics Inc. (ENGN): Director
- ESSA Pharma Inc. (EPIX): Director
Glickman Richard M
CIK: 0001352637
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
